A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma

NCT06753747 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Esophagus Cancer

Interventions

DRUG: Palbociclib
DRUG: Afatinib(30mg)
DRUG: Afatinib(40mg)
DRUG: Afatinib(RP2D)

Sponsor

West China Hospital